header
December 17, 2020

In This Issue
Advisory Panel Recommends Moderna Vaccine, FDA Expected to Authorize Emergency Use
Update to Our Special Edition Wednesday Vaccine Newsletter
FDA Authorizes First OTC COVID-19 Test
Maine Public Radio Reports 32 COVID-19 Cases Linked To Bangor Hospital Outbreak
MaineCare Section 17 Assertive Community Treatment (ACT) Service Cap
Attention FQHCs and RHCs: Reimbursing Telehealth Services, CR 98696
Current FDA Drug Shortages
Not Much COVID Relief Movement from Congress
Maine CDC Physicians To Host Regular Clinician COVID Vaccine Info Sessions
PPE Available Through the MMA & ActionPPE
Maine Medical Association Enduring Education Opportunity
MICIS Opioid Prescribing Presentation & Individual Academic Detailing Sessions
Hanley's PELI Advanced Course Enrollment is OPEN!
A Message from Maine Responds: Volunteer Opportunity
MAINE LEGISLATURE
State Legislative Committees Announced
UPCOMING EVENTS
Upcoming Specialty Society Programs & Meetings
Webinar: “Radon Risk Reduction: The Current Policy Landscape in the US and the Maine Perspective” January 12, 2020
Caring for LGBTQ+ Youth in Maine - Emphasis on the 'T' - Half-day Symposium on Saturday, January 23
MOA VIRTUAL Midwinter Symposium - Feb 12-14, 2021
Maine CDC Annual Prevention Professionals Conference - March 2-3, 2021
HEALTHCARE EMPLOYMENT OPPORTUNITIES
Behavioral Health Clinician
Psychiatric Nurse Practitioner
Physician (BC/BE in Family Medicine)

 
Search Back Issues



 

 

 


Follow Us:
Advisory Panel Recommends Moderna Vaccine, FDA Expected to Authorize Emergency Use

The US FDA’s Vaccines and Related Biological Products Advisory Committee voted Thursday to recommend emergency use authorization (EUA) of Moderna’s coronavirus vaccine. The FDA will now review the advisory committee's vote and decide whether to authorize emergency use nationwide.

FDA Moderna Briefing Document (PDF)

FDA Statement on Vaccines and Related Biological Products Advisory Committee Meeting

The excitement and expectations associated with the Moderna vaccine cannot be overstated and it will surely benefit non-hospital based outpatient physicians and staff. It is more easily transported and stored, making it more accessible to broader groups, including independent physician practices located in both suburban and rural areas. Unlike Pfizer, it can be stored at normal freezer temperatures and it comes in much smaller batches.

Last week, Maine CDC released initial projections that 24,200 doses are expected for first week of a Moderna delivery. Of the 24,200 total, 22,700 will go to hospitals and another 1,500 to be split between Androscoggin Home Health Services, Mid Coast Parkview Health (CHANS), MaineHealth Care at Home, Houlton Band of Maliseets, and Maine EMS.

Related FDA information:

COVID-19 Vaccines (FDA)

COVID-19 ACIP Vaccine Recommendations (ACIP)

Emergency Use Authorization for Vaccines Explained

Emergency Use Authorization for Vaccines to Prevent COVID-19

Development and Licensure of Vaccines to Prevent COVID-19

Washington Post: FDA vows to move 'rapidly’ to authorize second coronavirus vaccine

 

Next Article >

[ return to top ]

To ensure delivery of Maine Medicine Weekly Update,
please add 'info@mainemed.com' to your email address book or Safe Sender List.
If you are still having problems receiving our communications,
see our white-listing page for more details: http://www.commpartners.com/website/white-listing.htm


Unsubscribe here

For more information or to contact us directly, please visit www.mainemed.com | ©